OPKO Health, Inc.
0KCS.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.16B
Close$
Share Statistics
| Market cap | $1.16 Billion |
|---|---|
| Enterprise Value | $1.26 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -2.82% |
|---|---|
| Return on Assets | -1.82% |
| Return on Invested Capital | -3.38% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.14 |
| Enterprise Value to EBIT | -22.1 |
| Enterprise Value to Net Income | -38 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 27, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$131.23 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$136.62 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Opko Health Inc
2,275 employees
CEO: Phillip Frost OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diag...